{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T15:50:53Z","timestamp":1762098653508,"version":"build-2065373602"},"reference-count":16,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100013015","name":"Cedars-Sinai Medical Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013015","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","onlinejcf.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiac Failure"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.cardfail.2022.01.004","type":"journal-article","created":{"date-parts":[[2022,1,15]],"date-time":"2022-01-15T10:54:50Z","timestamp":1642244090000},"page":"960-962","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Biology or Disparity? Untangling Racial Differences in Val122Ile Transthyretin Cardiac Amyloidosis"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4492-2691","authenticated-orcid":false,"given":"MICHELLE M.","family":"KITTLESON","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cardfail.2022.01.004_bib0001","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1161\/CIRCULATIONAHA.116.021612","article-title":"Nonbiopsy diagnosis of cardiac transthyretin amyloidosis","volume":"133","author":"Gillmore","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2022.01.004_bib0002","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1093\/eurheartj\/ehx350","article-title":"Unveiling transthyretin cardiac amyloidosis and its predictors among elderly patients with severe aortic stenosis undergoing transcatheter aortic valve replacement","volume":"38","author":"Casta\u00f1o","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cardfail.2022.01.004_bib0003","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1093\/eurheartj\/ehv338","article-title":"Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction","volume":"36","author":"Gonzalez-Lopez","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cardfail.2022.01.004_bib0004","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1056\/NEJMoa1805689","article-title":"Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy","volume":"379","author":"Maurer","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2022.01.004_bib0005","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1161\/CIR.0000000000000792","article-title":"Cardiac amyloidosis: evolving diagnosis and management: a scientific statement from the American Heart Association","volume":"142","author":"Kittleson","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2022.01.004_bib0006","doi-asserted-by":"crossref","first-page":"E2403","DOI":"10.1002\/humu.22619","article-title":"Online registry for mutations in hereditary amyloidosis including nomenclature recommendations","volume":"35","author":"Rowczenio","year":"2014","journal-title":"Hum Mutat"},{"key":"10.1016\/j.cardfail.2022.01.004_bib0007","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3109\/13506129.2015.1051219","article-title":"Prevalence of the amyloidogenic transthyretin (TTR) V122I allele in 14\u2009333 African-Americans","volume":"22","author":"Jacobson","year":"2015","journal-title":"Amyloid"},{"key":"10.1016\/j.cardfail.2022.01.004_bib0008","doi-asserted-by":"crossref","first-page":"122","DOI":"10.2459\/JCM.0000000000000290","article-title":"The Val142Ile transthyretin cardiac amyloidosis: not only an Afro-American pathogenic variant? A single-centre Italian experience","volume":"17","author":"Cappelli","year":"2016","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"10.1016\/j.cardfail.2022.01.004_bib0009","article-title":"Racial differences in Val122Ile-associated transthyretin cardiac amyloidosis","author":"Batra","year":"2021","journal-title":"J Cardiac Fail"},{"key":"10.1016\/j.cardfail.2022.01.004_bib0010","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1161\/CIRCULATIONAHA.118.038169","article-title":"Natural history, quality of life, and outcome in cardiac transthyretin amyloidosis","volume":"140","author":"Lane","year":"2019","journal-title":"Circulation"},{"issue":"Suppl 1","key":"10.1016\/j.cardfail.2022.01.004_bib0011","doi-asserted-by":"crossref","first-page":"P22","DOI":"10.1186\/1750-1172-10-S1-P22","article-title":"Patient experience with hereditary and senile systemic amyloidoses: a survey from the Amyloidosis Research Consortium","volume":"10","author":"Lousada","year":"2015","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.cardfail.2022.01.004_bib0012","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.017543","article-title":"Sex and race ethnic disparities in door-to-CT time in acute ischemic stroke: the Florida Stroke Registry","volume":"10","author":"Polineni","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.cardfail.2022.01.004_bib0013","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/HCR.0000000000000203","article-title":"Disparities in cardiac rehabilitation participation in the United States: a systematic review and meta-analysis","volume":"37","author":"Sun","year":"2017","journal-title":"J Cardiopulmon Rehab Preven"},{"key":"10.1016\/j.cardfail.2022.01.004_bib0014","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.jchf.2018.02.015","article-title":"African Americans are less likely to receive care by a cardiologist during an intensive care unit admission for heart failure","volume":"6","author":"Breathett","year":"2018","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cardfail.2022.01.004_bib0015","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.hrthm.2008.12.018","article-title":"Ethnic and racial disparities in cardiac resynchronization therapy","volume":"6","author":"Farmer","year":"2009","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cardfail.2022.01.004_bib0016","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.118.005008","article-title":"Temporal trends in contemporary use of ventricular assist devices by race and ethnicity","volume":"11","author":"Breathett","year":"2018","journal-title":"Circul Heart Fail"}],"container-title":["Journal of Cardiac Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916422000100?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916422000100?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T06:46:45Z","timestamp":1761029205000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071916422000100"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":16,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S1071916422000100"],"URL":"https:\/\/doi.org\/10.1016\/j.cardfail.2022.01.004","relation":{},"ISSN":["1071-9164"],"issn-type":[{"type":"print","value":"1071-9164"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biology or Disparity? Untangling Racial Differences in Val122Ile Transthyretin Cardiac Amyloidosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiac Failure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cardfail.2022.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.cardfail.2021.12.016","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}